116 related articles for article (PubMed ID: 37551163)
1. Apparent Variation in Measurement Size of Colorectal Cancer Metastases to the Liver on Dual Contrast MRI.
Ngnitewe Massa'a R; Wawrzyn P; Mao L; Reeder SB; Kelcz F; Wentland AL
J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):12-18. PubMed ID: 37551163
[TBL] [Abstract][Full Text] [Related]
2. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
[TBL] [Abstract][Full Text] [Related]
5. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
[TBL] [Abstract][Full Text] [Related]
7. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
Bhayana R; Baliyan V; Kordbacheh H; Kambadakone A
Eur Radiol; 2021 Mar; 31(3):1359-1366. PubMed ID: 32886204
[TBL] [Abstract][Full Text] [Related]
9. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
Canellas R; Patel MJ; Agarwal S; Sahani DV
Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
[TBL] [Abstract][Full Text] [Related]
10. Measurements of Hepatic Metastasis on MR Imaging:: Assessment of Interobserver and Intersequence Variability.
Karademir I; Ward E; Peng Y; Wise L; Buckle C; Kunnavakkam R; Oto A
Acad Radiol; 2016 Feb; 23(2):132-43. PubMed ID: 26548855
[TBL] [Abstract][Full Text] [Related]
11. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
[No Abstract] [Full Text] [Related]
12. Utility of Wavelet Denoising with Geometry Factor Weighting for Gadoxetic Acid-enhanced Hepatobiliary-phase MR Imaging.
Kondo S; Nakamura Y; Higaki T; Nishihara T; Takizawa M; Shirai T; Fujimori M; Bito Y; Narita K; Sueoka T; Honda Y; Tani C; Awai K
Magn Reson Med Sci; 2023 Apr; 22(2):241-252. PubMed ID: 35650028
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard.
Costa EA; Cunha GM; Smorodinsky E; Cruite I; Tang A; Marks RM; Clark L; Wolfson T; Gamst A; Sicklick JK; Hemming A; Peterson MR; Middleton MS; Sirlin CB
Radiology; 2015 Sep; 276(3):775-86. PubMed ID: 25875972
[TBL] [Abstract][Full Text] [Related]
14. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
Eur J Radiol; 2021 Oct; 143():109887. PubMed ID: 34454297
[TBL] [Abstract][Full Text] [Related]
15. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A
Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059
[TBL] [Abstract][Full Text] [Related]
16. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
Pan J; Li W; Gu L; Liu C; Zhang K; Hong G
Eur Radiol; 2022 Nov; 32(11):7883-7895. PubMed ID: 35579711
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary phase images of gadoxetic acid-enhanced MRI may improve accuracy of predicting the size of hepatocellular carcinoma at pathology.
Dong SY; Yang YT; Wang WT; Zhu S; Sun W; Zeng MS; Rao SX
Acta Radiol; 2022 Jun; 63(6):734-742. PubMed ID: 33969700
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors.
Ryeom H; Chang Y; Park SY; Cho SH; Yeo B; Je H; Baek J
Medicine (Baltimore); 2023 Nov; 102(46):e36176. PubMed ID: 37986292
[TBL] [Abstract][Full Text] [Related]
20. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.
Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J
World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
